Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
gene therapy
genentech
2
×
ipo
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
10x genomics
abbvie
acetylon pharmaceuticals
allergan
ambys medicines
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
biogen
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
cell therapy
centers for disease control and prevention
chinook therapeutics
clinical trials
clostridium difficile
community-acquired bacterial pneumonia
What
biotech
2
×
aiming
ambys
august
big
bio
busy
control
days
deadly
deal
debuted
decisions
devices
diseases
drugs
fda
formed
future
launch
legacy
liver
make
medicines
new
news
nods
opioid
past
regulatory
roundup
sarepta’s
seven
shkreli’s
slow
startup
stumble
suits
takeda
tends
Language
unset
Current search:
genentech
×
biotech
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?